Currently, you are not logged in to my.chemeurope.com. Therefore, you can remember a maximum of 5 contents.
Possible antitumor substances in red wine are formed during ageing in oak barrels
Polyphenols not only give red wine its characteristic dry flavor, they are also
the basis for the recent good reputation of this stimulant as a true health
drink. They are believed to prevent heart disease and atherosclerosis. French
researchers working with Stéphane Quideau have now discovered more examples of
polyphenols in red wine, and these could have anticancer activity.
Polyphenols are a large class of substances that act as tannins and pigments in many fruits and vegetables. "A number of these substances have already made their way into medicine, but the potential has not been exhausted by a long shot," says Quideau. He and his team have now found another interesting compound in red wine. Acutissimin A is a flavano ellagitannin, meaning that it has both flavonoid and tannin components. The substance was first discovered in the oak species Quercus acutissima, from which it takes its name. What makes acutissimin A so attractive is its inhibitory effect on DNA topoisomerase II, because this enzyme is a target in cancer treatment. Acutissimin A inhibits this enzyme 250 times more strongly than the clinically used antitumor agent Etoposid.
The French team was able to produce acutissimin A semisynthetically in the laboratory by binding together the flavanoid catechin and the tannin vescalagin. If an isomer of catechin, epicatechin, is used, a closely related but previously unknown compound, which the researchers called "epiacutissimin", is formed. The team was later also able to detect this substance in red wine extracts.
How do acutissimin and epiacutissimin get into red wine? It's the ageing in oak barrels! Says Quideau: "The grape juice contains the flavonoid precursors catechin and epicatechin. During storage, the alcoholic liquid then extracts a whole bouquet of substances out of the oak barrels, including the necessary co-reactant, vescalagin." Quideau and his colleagues won't go so far as to call wine a cancer preventative. But one can hardly wait to see what surprises red wine has in store for us next. The probability is high that these precious drops contain more tannin hybrid molecules with interesting pharmacological activity.
- cardiovascular diseases
- 1Researchers use light to convert abundant lignin into plastic that can be continually recycled
- 2This ‘Harry Potter’ light sensor achieves magically high efficiency of 200 per cent
- 3Crab shells could help power the next generation of rechargeable batteries
- 4Toilet paper is an unexpected source of PFAS in wastewater
- 5A greener alternative for aviation fuel
- 6IFF Announces the Sale of Flavor Specialty Ingredients Business to Exponent
- 7An international team presents a potentially groundbreaking discovery for nitrogen chemistry
- 8BASF to invest in its aroma ingredients business by expanding its global production footprint with new plants in China and Germany
- 9New corrosion protection that repairs itself
- 10Efficient recovery of lithium from end-of-life batteries and battery production scrap
- Green hydrogen: How photoelectrochemical water splitting may become competitive
- How do we want to heat our homes in the future?
- In search of the 'holy grail': researchers observe lithium ions in real time
- Shape memory for nano-sized objects
- A breakthrough in big data processing helps trace chemicals in complex mixtures